根据名称进行药物检索

Trandate (Labetalol Injection)与哮喘/ COPD

Trandate (Labetalol Injection)与哮喘/ COPD安全配伍检测的结果。

检测结果:

Trandate (Labetalol Injection) <> 哮喘/ COPD

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

一些貝塔-肾上腺素受体阻断剂(即，非心臟選擇性 β受体阻滞剂)是禁忌支气管哮喘患者或与一个历史上支气管哮喘病或严重慢性阻塞性肺疾病。在一般情况下，β-肾上腺素受体阻断剂，不应使用在患者与支氣管痙攣疾病。貝塔封锁可能会产生不利影响肺功能通过抵消的支气管扩张产生了通过儿茶酚胺刺激的貝塔-2受体。如果受体阻滞剂治疗是必要的，在这些患者中，一个代β-1的选择性(例如洛尔、美托洛尔、倍他洛尔)被认为更加安全，但应谨慎使用仍然。心臟選擇性不是绝对的，可能会丢失较大的剂量。

来源

Horvath JS, Woolcock AJ, Tiller DJ, Donnelly P, Armstrong J, Caterson R "A comparison of metoprolol and propranolol on blood pressure and respiratory function in patients with hypertension." Aust N Z J Med 8 (1978): 1-6
Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998):
Falliers CJ, Vincent ME, Medakovic M "Effect of single doses of labetalol, metoprolol, and placebo on ventilatory function in patients with bronchial asthma: interaction with isoproterenol." J Asthma 23 (1986): 251-60
"Product Information. Kerlone (betaxolol)." Searle, Skokie, IL.
"Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals, East Hanover, NJ.
"Product Information. Cartrol (carteolol)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Inderal (propranolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Adam WR, Meagher EJ, Barter CE "Labetalol, beta blockers, and acute deterioration of chronic airway obstruction." Clin Exp Hypertens A A4 (1982): 1419-28
Raine JM, Palazzo MG, Kerr JH, Sleight P "Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane." Br Med J 282 (1981): 548-9
Durant PA, Joucken K "Bronchospasm and hypotension during cardiopulmonary bypass after preoperative cimetidine and labetalol therapy." Br J Anaesth 56 (1984): 917-20
Benson MK, Berrill WT, Cruickshank JM, Sterling GS "A comparison of four B-adrenoceptor antagonists in patients with asthma." Br J Clin Pharmacol 5 (1978): 415-9
"Product Information. Blocadren (timolol)." Merck & Co, Inc, West Point, PA.
"Product Information. Brevibloc (esmolol)." DuPont Pharmaceuticals, Wilmington, DE.
"Product Information. Visken (pindolol)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
"Product Information. Levatol (penbutolol)." Reed and Carnrick, Jersey City, NJ.
"Product Information. Trandate (labetalol)." Glaxo Wellcome, Research Triangle Park, NC.
"Product Information. Sectral (acebutolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Schoenberger JA, Croog SH, Sudilovsky A, et al "Self-reported side effects from antihypertensive drugs: a clinical trial." Am J Hypertens 3 (1990): 123-32
Chodosh S, Tuck J, Blasucci DJ "The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics." J Cardiovasc Pharmacol 11 (1988): s18-24
"Product Information. Zebeta (bisoprolol)." Lederle Laboratories, Wayne, NJ.
Stephen SA "Unwanted effects of propranolol." Am J Cardiol 18 (1966): 463-72
"Product Information. Coreg (carvedilol)." SmithKline Beecham, Philadelphia, PA.
Morris R, Bulteau P "Respiratory arrest after beta-blocker in an asthmatic patient." Med J Aust 2 (1980): 576
"Product Information. Corgard (nadolol)." Bristol-Myers Squibb, Princeton, NJ.
"Product Information. Normodyne (labetalol)." Schering Laboratories, Kenilworth, NJ.
van Zyl AI, Jennings AA, Bateman ED, Opie LH "Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension." Chest 95 (1989): 209-13
Mashford ML, Coventry D, Hecker R, et al. "Adverse Drug Reactions Advisory Committee: ADRAC report for 1980." Med J Aust 1 (1982): 416-9
"Product Information. Betapace (sotalol)." Berlex, Richmond, CA.
"Product Information. Tenormin (atenolol)." ICN Pharmaceuticals Inc, Cost Mesa, CA.